BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hung PD, Schubert ML, Mihas AA. Zollinger-Ellison syndrome. Curr Treat Options Gastro 2003;6:163-70. [DOI: 10.1007/s11938-003-0017-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Orlando LA, Lenard L, Orlando RC. Chronic Hypergastrinemia: Causes and Consequences. Dig Dis Sci 2007;52:2482-9. [DOI: 10.1007/s10620-006-9419-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
2 Teixeira MZ. Rebound effect of modern drugs: serious adverse event unknown by health professionals. Rev Assoc Med Bras (1992) 2013;59:629-38. [PMID: 24211013 DOI: 10.1016/j.ramb.2013.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hughes SM. Canine gastrinoma: a case study and literature review of therapeutic options. N Z Vet J 2006;54:242-7. [PMID: 17028663 DOI: 10.1080/00480169.2006.36705] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
4 Jackson JE. Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab. 2005;19:229-239. [PMID: 15763697 DOI: 10.1016/j.beem.2004.10.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
5 Schubert ML, Rehfeld JF. Gastric Peptides-Gastrin and Somatostatin. Compr Physiol 2019;10:197-228. [PMID: 31853955 DOI: 10.1002/cphy.c180035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Zhang WD, Liu DR, Wang P, Zhao JG, Wang ZF, Chen LI. Clinical treatment of gastrinoma: A case report and review of the literature. Oncol Lett 2016;11:3433-7. [PMID: 27123130 DOI: 10.3892/ol.2016.4397] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
7 Norton JA, Fraker DL, Alexander HR, Jensen RT. Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome. Ann Surg. 2012;256:509-517. [PMID: 22868363 DOI: 10.1097/sla.0b013e318265f08d] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
8 Napolitano L. Refractory Peptic Ulcer Disease. Gastroenterology Clinics of North America 2009;38:267-88. [DOI: 10.1016/j.gtc.2009.03.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
9 Blonski WC, Katzka DA, Lichtenstein GR, Metz DC. Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease. Eur J Gastroenterol Hepatol 2005;17:441-4. [PMID: 15756097 DOI: 10.1097/00042737-200504000-00008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 Weiner RE, Thakur ML. Radiolabeled peptides in oncology: role in diagnosis and treatment. BioDrugs. 2005;19:145-163. [PMID: 15984900 DOI: 10.2165/00063030-200519030-00002] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 4.4] [Reference Citation Analysis]
11 Kim HU. Diagnostic and Treatment Approaches for Refractory Peptic Ulcers. Clin Endosc 2015;48:285-90. [PMID: 26240800 DOI: 10.5946/ce.2015.48.4.285] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
12 Metz DC, Sostek MB, Ruszniewski P, Forsmark CE, Monyak J, Pisegna JR. Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. Am J Gastroenterol. 2007;102:2648-2654. [PMID: 17764495 DOI: 10.1111/j.1572-0241.2007.01509.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
13 Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842-1860. [PMID: 18474247 DOI: 10.1053/j.gastro.2008.05.021] [Cited by in Crossref: 269] [Cited by in F6Publishing: 222] [Article Influence: 19.2] [Reference Citation Analysis]
14 Guzzo JL, Duncan M, Bass BL, Bochicchio GV, Napolitano LM. Severe and Refractory Peptic Ulcer Disease: The Diagnostic Dilemma. Dig Dis Sci 2005;50:1999-2008. [DOI: 10.1007/s10620-005-2999-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
15 Devlin JW, Welage LS, Olsen KM. Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics. Ann Pharmacother. 2005;39:1844-1851. [PMID: 16204393 DOI: 10.1345/aph.1g176] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]